1315 Capital is a private investment firm with over $965 million under management that provides expansion and growth capital to commercial-stage healthcare services, medical technology, medtech & pharma outsourcing, and health & wellness companies. We target markets where high-quality management teams can rapidly scale platform companies into large and important businesses that positively impact patients, physicians, and the broader healthcare system.
The 1315 Capital investment team combines financial and business development expertise with deep industry knowledge to support the growth of our portfolio companies.
1315 Capital employs an Operating Team model to navigate diligence, drive decisions, and seeks to achieve premium exits.
1315 Capital has a large network that it leverages for management talent, advisors, deal sourcing, diligence, and boards roles.
February 24, 2023
January 09, 2023
November 02, 2022
Global company manufacturing and distributing medical simulation and education products.
Provider of AI-enabled decision support technology for global life sciences sales and marketing teams.
Medical technology company providing hydrophilic coatings to medical device manufacturers.
Cost-containment service company providing hospitals with turn key liquidation of used equipment.
Medical equipment and supply company that serves pediatric and adult patient populations with special needs.
Cosmeceutical company providing natural, mineral-based approach to skin protection and skin health.
Dermatology company committed to delivering innovative prescription therapies to dermatologists.
Oncology diagnostics company that provides oncologists and pathologists with comprehensive testing solutions in hematology and solid tumor molecular profiling.
Multi-center services company providing transcranial magnetic stimulation to mental health patients.
Healthcare benefits company providing reference based pricing, claims processing, and stop loss insurance
Staffing and training company that provides outsourced support for extracorporeal membrane oxygenation (ECMO) and perfusion in hospitals.
Cost-containment service company focused on reprocessing single-use medical devices.
Bioinformatics company providing evidence-based, clinically beneficial molecular diagnostic tests and pathology services.
Specialty pharmaceutical company focused on nutraceutical and women’s health products.
Medical technology company offering only FDA approved treatment to permanently reduce underarm sweat, odor, and hair.
Medical technology company offering ultrasonic surgical tools and advanced wound care products to healthcare providers.
Nutrition technology company helping its users improve their metabolic health through personalized data and dietitian support.
Medical device company focused on the orthopedic oncology market.
Specialty clinical research organization focused on metabolic diseases including certain liver diseases, diabetes, and obesity.
Pre-clinical contract research organization providing drug discovery services.
Medical device company providing functional electrical stimulation to neurological rehabilitation patients.
Forensic genomics company providing next-generation sequencing equipment, solutions, and software.